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Background: The position of arterial ligation during laparoscopic anterior rectal resection with total mesorectal
excision can affect genito-urinary function, bowel function, oncological outcomes, and the incidence of anastomotic
leakage. Ligation to the inferior mesenteric artery at the origin or preservation of the left colic artery are both widely
performed in rectal surgery. The aim of this study is to compare the incidence of genito-urinary dysfunction,
anastomotic leak and oncological outcomes in laparoscopic anterior rectal resection with total mesorectal excision
with high or low ligation of the inferior mesenteric artery in a controlled randomized trial.
Methods/design: The HIGHLOW study is a multicenter randomized controlled trial in which patients are randomly
assigned to high or low inferior mesenteric artery ligation during laparoscopic anterior rectal resection with total
mesorectal excision for rectal cancer. Inclusion criteria are middle or low rectal cancer (0 to 12 cm from the anal
verge), an American Society of Anesthesiologists score of I, II, or III, and a body mass index lower than 30. The
primary end-point measure is the incidence of post-operative genito-urinary dysfunction. The secondary end-point
measure is the incidence of anastomotic leakage in the two groups. A total of 200 patients (100 per arm) will
reliably have 84.45 power in estimating a 20% difference in the incidence of genito-urinary dysfunctions. With a
group size of 100 patients per arm it is possible to find a significant difference (α = 0.05, β = 0.1555). Allowing for
an estimated dropout rate of 5%, the required sample size is 212 patients.
Discussion: The HIGHLOW trial is a randomized multicenter controlled trial that will provide evidence on the merits
of the level of arterial ligation during laparoscopic anterior rectal resection with total mesorectal excision in terms
of better preserved post-operative genito-urinary function.
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Colorectal cancer incidence and mortality rates vary
around the world. Globally, colorectal cancer is the third
most commonly diagnosed cancer in men and the second
in women [1]. Surgical treatment of rectal cancer has
changed radically in recent years. The introduction of total
mesorectal excision [2], neo-adjuvant therapy protocols
[3], and the laparoscopic approach [4] has made rectal
cancer treatment a multidisciplinary management.
While laparoscopic resection of colon cancer has slowly
gained acceptance worldwide, the role of laparoscopy in
the treatment of rectal cancer is still controversial [4,5].
The laparoscopic treatment of rectal cancer raises specific
issues related to its anatomical location: difficult exposure
in a narrow pelvis, challenging nerve-sparing techniques,
low intestinal transection, and total mesorectal excision
[6,7]. Ligation of the inferior mesenteric artery at the ori-
gin and mobilization of the splenic flexure are not rou-
tinely done worldwide [8-11]. The need for well-designed
studies to compare the different vascular approaches in
rectal surgery has been clearly expressed [12-14].
The level of arterial ligation can affect genito-urinary
function (injury to the superior hypogastric plexus), the
extent (and yield) of lymphadenectomy, and distal co-
lonic arterial perfusion (especially in older people, where
distal colonic arterial perfusion could be deficient due to
degenerative disease), and causesympathetic nerve in-
jures [15-19]. Moreover, colonic stump blood supply and
anastomosis tension are the main factors in developing
leaks in rectal surgery [20-26] and are dependent on the
level of ligation.
The aim of this study is to compare the incidence of
genito-urinary dysfunction and, secondarily, the inci-
dence of anastomotic leakage and the oncological out-
comes in laparoscopic anterior rectal resection with total
mesorectal excision with high or low ligation of the in-
ferior mesenteric artery in a controlled randomized trial.
Methods/design
Study design
The HIGHLOW study is a multicenter controlled trial.
Patients are randomly assigned to high or low inferior mes-
enteric artery during laparoscopy once the surgeon has
confirmed intraoperatively, that all inclusion criteria are
fulfilled and that the procedure is feasible. All participating
surgeons have performed at least 20 laparoscopic proce-
dures per year during the past 5 years. Randomization is
performed using sealed envelopes (Figure 1).
Primary and secondary endpoint measures
The primary end-point measure is the incidence of post-
operative genito-urinary dysfunction compared with a
preoperative base-line assessment in both groups. The
secondary endpoint measures are the incidence of clinicalor subclinical anastomotic leakage in the two groups and
the oncological outcomes in both groups.
The incidence of clinical or subclinical anastomotic
leaks will be determined either as the presence of a radio-
logically, endoscopically, or surgically proved fistula or as
the presence of a subclinical leak observed by endoscopic
examination 30 days after surgery in both groups.
Oncological outcomes will be assessed in terms of re-
trieved lymph nodes, number of positive lymph nodes
on the root of the inferior mesenteric artery total num-
ber of lymph nodes of the mesorectum, and positive
lymph nodes of the mesorectum, disease-free survival,
overall survival, local recurrence, distant metastasis in
both groups.
Participating centers and
Five non-academic public Italian hospitals will enroll
patients.
Study population
The study population consists of patients with cancer of
the lower two-thirds of the rectum, who are eligible for
laparoscopic low rectal resection with total mesorectal
excision.
Inclusion criteria are middle or low rectal cancer (from
0 to 12 cm from the dental line), an American Society of
Anesthesiologists score of I, II, or III, and a body mass
index less than 30. The study will include both preopera-
tively irradiated and non-irradiated patients.
Exclusion criteria are prior surgery on the abdominal
aorta and proven arteriosclerosis of the inferior mesen-
teric artery and its branches.
The study will include both pre operatively irradiated
and non-irradiated patients.
Exclusion criteria: prior surgery on the abdominal aorta,
proven arterosclerosis of IMA and IMA branches.
Ethical considerations
This study is conducted in accordance with the princi-
ples of the Declaration of Helsinki and “good clinical
practice” guidelines. The study was approved by a Central
Ethics Committee (list of names of the Ethical Body in
Additional file 1). Prior to randomization written in-
formed consent will be obtained from all patients.
Preoperative evaluation
Patients with a preoperative diagnosis of adenocarcinoma
of the middle or lower rectum and who satisfy the inclu-
sion criteria will be asked to participate in the HIGHLOW
trial. Once informed consent is obtained, investigations
will include questionnaires for the International Index
of Erectile Function [27], International Consultation on
Incontinence Questionnaire [28], International Prosta-
tic Symptoms Score, Female Sexual Function Inde [29]
Randomization by sealed envelops 
Patients with tumor of the middle or lower third of the rectum eligible for LAR with TME 
Check inclusion and exclusion criteria 
Pre-operative genitor-urinary function assessment 
Post-operative genito-urinary function assessment Post-
operative endoscopic anastomosis evaluation 
(1 month from surgery)
High Tie Group Low Tie group 
Post-operative genito-urinary function evaluation  
(9 months from surgery)
Figure 1 Study flowchart. LAR: Laparoscopic Anterior Resection. TME: Total Mesorectal Excision.
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void bladder volume will be performed pre-operatively
for all patients.
Surgery
The following steps are required in all cases, independ-
ently of randomization.
Laparoscopic anterior rectal resection with total mesorectal
excision (without pelvic cylindrical excixion)
The first step consist in the opening of the left part of
the gastrocolic ligament and the division of the left part
of transverse mesocolon. The splenocolic and phreno-
colic attachments are then divided, achieving complete
dissection of the left colonic angle. The pelvic perito-
neum is opened below the sacral promontory and the
hypogastric nerves are identified and preserved. The
common iliac veins, the genitofemoral nerve, the gona-
dic vessels, and the left ureter are successively identified
and preserved.For high ligation
The opening of the peritoneum proceeds cephalad, to-
wards the duodenojejunal angle of Treitz, and the mes-
enteric root is incised 1 cm below the inferior margin of
the pancreas. The aortomesenteric window is opened wide
and the inferior mesenteric vessels are exposed. The infer-
ior mesenteric artery is ligated and divided at 2 cm from
its origin. The inferior mesenteric vein is ligated and di-
vided below the pancreatic margin
For low ligation
The opening of the peritoneum proceeds upward and then
laterally towards the sigmoid colon. The leftcolic artery is
identified and preserved while low ligation of the inferior
mesenteric artery (the superior hemorrhoidal artery) is per-
formed. Lymphadenectomy is performed medially along
the inferior mesenteric artery as far as 2 cm from the aorta.
For both groups, dissection is then continued windowing
Toldt’s and Gerota’s fascias up to the parietocolic gutter.
Intra-pelvic dissection is carried out through standardized
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peritoneal fold in the pelvis. Mesorectal excision starts pos-
teriorly by dissection through Heald’s “holy plane”, it car-
ries on towards the lateral region of the rectum, sparing
the lateral part of the lateral rectal ligaments, and extends
on the anterior side in front of Denonvilliers’ fascia.
Post-operative evaluation
Colonoscopy will be performed 30 days after surgery to
evaluate anastomosis (leakage, signs of ischemia) [26].
Accurate description and pictures of the anastomosis will
be produced. Questionnaires for the Internation Index of
Erectile Function [27], International Consultation on In-
continence Questionnaire [28], International Prostatic
Symptoms Score, and Female Sexual Function Index [29]
will be administrated, and uroflowmetry and ultrasound
measurement of post-void bladder volume will be per-
formed 1 and 9 months post-operatively. Retrieved lymph
nodes will be collected from the histopathological examin-
ation, and the number of positive lymph nodes on the root
of the inferior mesenteric artery, the total number of
lymph nodes on the mesorectum, and the number of posi-
tive lymph nodes on the mesorectum will be recorded
Oncological follow up will be carried out for 5 years, ac-
cording to National Comprehensive Cancer Network
Guidelines [30] Version 1.2015 Rectal Cancer/Surveillance
(www.nccn.org).
Sample size calculation
A two tail Fischer exact test applied to two cohorts of 100
patients each will have 84.45 power in estimating a 20%
difference in the incidence of genitor-urinary dysfunctions.
With a group size of 100 patients per arm it is possible to
find a significant difference (α= 0.05, β= 0.1555).
With a drop-out estimated rate of 5%, the required
sample size is 212 patients. If the number of drop-outs
exceed 5%, we plan to ask the ethics committee to enroll
more patients to be able to keep the power of analysis
well above 80%.
Statistical analysis
The Primary end-point measure will be evaluated using
Fisher’s exact test (one-sided). The different incidences
of genitor-urinary dysfunction according to sex and the
results of each questionnaire will be evaluated using the
Mann–Whitney U test and the t-test. Mc Nemar’s test
will be used to evaluate changes in questionnaires results
overtime. Statistical analysis will be performed in accor-
dance with the intention-to-treat principle.
Data collection and monitoring
Data will be collected daily using an Access database by
one physician for each hospital and referred to a re-
search fellow who will monitor the included data for allinstitutions. Patients will fill out questionnaires during
pre and post-operative physical examinations. There will
be regular contact between the study coordinators and
the participating centers through scheduled meetings
every 3 months. Uroflowmetry and ultrasound measure-
ment of post-void bladder volume will be performed by
the urologists of each institution, colonoscopies will be
performed by endoscopists of each institution.
Discussion
The discussion of the benefits or disadvantages between
high tie and low tie in rectal surgery continues to be de-
bated. Retrospective evaluations [9,31] have not produced a
high level of significance regarding this issue. On the one
hand, the risk of poor blood supply of the anastomosis
could outweigh the oncological benefits of performing high
ligation of the inferior mesenteric artery routinely, on the
other hand a more powerful disease staging achieved with
high ligation of the inferior mesenteric artery is found to be
associated with an acceptable anastomotic leak rate. There
is an increased risk of poor colonic stump blood supply
when relying on the marginal artery alone, therefore, if this
artery is not adequate, a more extended intestinal resection
has to be performed, even if it is oncologically unnecessary.
Performing lymphadenectomy extending to the origin of
the inferior mesenteric artery even for low ligation provides
data on the disease involvement of apical nodes. A signifi-
cantly lower incidence of anastomotic leak in one or other
group could indicate a technical policy for patients for
which the vascular component might play a key role. Re-
duction of fistula in laparoscopic anterior rectal resection
will produce a significant improvement in quality of life for
these patients. Investigating pre and post-operatibegenitor-
urinary function will provide a more complete assessment
of the impact of laparoscopic anterior rectal resection on
functional outcomes. Arterial ligation far from the hypogas-
tric plexus could help in preserving pelvic autonomic func-
tions, giving a better quality of life to patients.
We expect the low tie group to present a lower rate of
genito-urinary function depression and post-operative
fistula because of the better blood supply provided and
better nerve sparing achieved.cpr
Trial status
The study is not yet open for participant recruitment.
Additional file
Additional file 1: Title and legend section.
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